Daybreak

There is practically no price control in India on patented cancer drugs that promise higher chances for survival

Show Notes

Despite winning the 'pharmacy of the world,' two out of five cancer patients in India have to borrow money and sell their assets to get treatment. 

The price of many innovative patented oncology drugs in India are as high as in developed countries making them inaccessible for a large section of patients.

Where are Indian cancer patients turning to for cheaper cancer medicines?

Tune in to find out.

What is Daybreak?

Business news is complex and overwhelming. It doesn’t have to be. Every day of the week, from Monday to Friday, Daybreak tells one business story that’s significant, simple and powerful.

Hosted from The Ken’s newsroom by Snigdha Sharma and Rachel Varghese, Daybreak relies on years of original reporting and analysis by some of India’s most experienced and talented business journalists.